Literature DB >> 28592445

Lymphocyte Galactocerebrosidase Activity by LC-MS/MS for Post-Newborn Screening Evaluation of Krabbe Disease.

Hsuan-Chieh Liao1,2, Zdenek Spacil1,3, Farideh Ghomashchi1, Maria L Escolar4, Joanne Kurtzberg5, Joseph J Orsini6, Frantisek Turecek1, C Ronald Scott7, Michael H Gelb8,9.   

Abstract

BACKGROUND: Deficiency of the lysosomal enzyme galactosylcerebrosidase (GALC) causes Krabbe disease. Newborn screening for Krabbe disease is ongoing, but improved methods for follow-up analysis of screen-positive babies are needed to better advise families and to optimize treatment. We report a new assay for the enzymatic activity of GALC in lymphocytes.
METHODS: T lymphocytes were isolated from venous blood by magnetic bead technology. The assay used a close structural analog of the natural substrate and LC-MS/MS to quantify the amount of product with the aid of a chemically identical internal standard.
RESULTS: The analytical range of the assay (ratio of assay response for the QC high standard to that from all non-enzymatic-dependent processes) was 20-fold greater than that for the conventional radiometric GALC assay. The LC-MS/MS could distinguish cells that were null in GALC from those that contained traces of active enzyme (down to 0.3% of normal). There was a good correlation between the level of residual GALC activity in lymphocytes and the severity of Krabbe disease.
CONCLUSIONS: The new assay can measure small amounts of residual GALC activity in leukocytes with high accuracy compared to previous assays and can contribute, along with genotyping, biomarker analysis, and neurological imaging, a better plan for post-newborn screening follow-up for Krabbe disease.
© 2017 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28592445      PMCID: PMC5533636          DOI: 10.1373/clinchem.2016.264952

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.

Authors:  Yijun Li; C Ronald Scott; Nestor A Chamoles; Ahmad Ghavami; B Mario Pinto; Frantisek Turecek; Michael H Gelb
Journal:  Clin Chem       Date:  2004-08-03       Impact factor: 8.327

2.  Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.

Authors:  Maria L Escolar; Michele D Poe; James M Provenzale; Karen C Richards; June Allison; Susan Wood; David A Wenger; Daniel Pietryga; Donna Wall; Martin Champagne; Richard Morse; William Krivit; Joanne Kurtzberg
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

3.  Newborn screening for Krabbe disease: the New York State model.

Authors:  Patricia K Duffner; Michele Caggana; Joseph J Orsini; David A Wenger; Marc C Patterson; Carl J Crosley; Joanne Kurtzberg; Georgianne L Arnold; Maria L Escolar; Darius J Adams; Mary R Andriola; Alan M Aron; Emma Ciafaloni; Alexandra Djukic; Richard W Erbe; Patricia Galvin-Parton; Laura E Helton; Edwin H Kolodny; Barry E Kosofsky; David F Kronn; Jennifer M Kwon; Paul A Levy; Jill Miller-Horn; Thomas P Naidich; Joan E Pellegrino; James M Provenzale; Stanley J Rothman; Melissa P Wasserstein
Journal:  Pediatr Neurol       Date:  2009-04       Impact factor: 3.372

Review 4.  Clinical management of Krabbe disease.

Authors:  Maria L Escolar; Tara West; Alessandra Dallavecchia; Michele D Poe; Kathleen LaPoint
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 5.  Krabbe disease: One Hundred years from the bedside to the bench to the bedside.

Authors:  David A Wenger; Mohammad A Rafi; Paola Luzi
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

6.  An improved method for the identification of patients and carriers of Krabbe's disease.

Authors:  D A Wenger; M Sattler; C Clark; H McKelvey
Journal:  Clin Chim Acta       Date:  1974-10-30       Impact factor: 3.786

7.  Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease.

Authors:  Wei-Lien Chuang; Josh Pacheco; X Kate Zhang; Monica M Martin; Chad K Biski; Joan M Keutzer; David A Wenger; Michele Caggana; Joseph J Orsini
Journal:  Clin Chim Acta       Date:  2013-02-16       Impact factor: 3.786

8.  A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation.

Authors:  Maria L Escolar; Michele D Poe; Holly R Martin; Joanne Kurtzberg
Journal:  Pediatrics       Date:  2006-08-21       Impact factor: 7.124

9.  Measurement of psychosine in dried blood spots--a possible improvement to newborn screening programs for Krabbe disease.

Authors:  Coleman T Turgeon; Joseph J Orsini; Karen A Sanders; Mark J Magera; Thomas J Langan; Maria L Escolar; Patricia Duffner; Devin Oglesbee; Dimitar Gavrilov; Silvia Tortorelli; Piero Rinaldo; Kimiyo Raymond; Dietrich Matern
Journal:  J Inherit Metab Dis       Date:  2015-03-12       Impact factor: 4.982

10.  Newborn screening for Krabbe disease in New York State: the first eight years' experience.

Authors:  Joseph J Orsini; Denise M Kay; Carlos A Saavedra-Matiz; David A Wenger; Patricia K Duffner; Richard W Erbe; Chad Biski; Monica Martin; Lea M Krein; Matthew Nichols; Joanne Kurtzberg; Maria L Escolar; Darius J Adams; Georgianne L Arnold; Alejandro Iglesias; Patricia Galvin-Parton; David F Kronn; Jennifer M Kwon; Paul A Levy; Joan E Pellegrino; Natasha Shur; Melissa P Wasserstein; Michele Caggana
Journal:  Genet Med       Date:  2016-01-21       Impact factor: 8.822

View more
  7 in total

1.  Leukocyte and Dried Blood Spot Arylsulfatase A Assay by Tandem Mass Spectrometry.

Authors:  Xinying Hong; Arun Babu Kumar; Jessica Daiker; Fan Yi; Martin Sadilek; Fabiola De Mattia; Francesca Fumagalli; Valeria Calbi; Roberta Damiano; Maria Della Bona; Giancarlo la Marca; Adeline L Vanderver; Amy T Waldman; Laura Adang; Omar Sherbini; Sarah Woidill; Teryn Suhr; Joanne Kurtzberg; Maria L Beltran-Quintero; Maria Escolar; Alessandro Aiuti; Alan Finglas; Amber Olsen; Michael H Gelb
Journal:  Anal Chem       Date:  2020-04-16       Impact factor: 6.986

2.  Psychosine, a marker of Krabbe phenotype and treatment effect.

Authors:  M L Escolar; B T Kiely; E Shawgo; X Hong; M H Gelb; J J Orsini; D Matern; M D Poe
Journal:  Mol Genet Metab       Date:  2017-05-22       Impact factor: 4.797

Review 3.  Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.

Authors:  Monique Piraud; Magali Pettazzoni; Pamela Lavoie; Séverine Ruet; Cécile Pagan; David Cheillan; Philippe Latour; Christine Vianey-Saban; Christiane Auray-Blais; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2018-03-19       Impact factor: 4.982

4.  Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease.

Authors:  Andrea N Crivaro; Juan M Mucci; Constanza M Bondar; Maximiliano E Ormazabal; Romina Ceci; Calogera Simonaro; Paula A Rozenfeld
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

5.  Compound heterozygous pathogenic variants in the GALC gene cause infant-onset Krabbe disease.

Authors:  Xiaoli Zhang; Guohui Niu; Panpan Song; Lijun Wang; Rui Han; Manman Chu; Qiliang Guo; Zhao Xu; Lihong Yan; Tianming Jia
Journal:  Transl Pediatr       Date:  2021-10

Review 6.  Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.

Authors:  Jennifer M Kwon; Dietrich Matern; Joanne Kurtzberg; Lawrence Wrabetz; Michael H Gelb; David A Wenger; Can Ficicioglu; Amy T Waldman; Barbara K Burton; Patrick V Hopkins; Joseph J Orsini
Journal:  Orphanet J Rare Dis       Date:  2018-02-01       Impact factor: 4.123

7.  Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease.

Authors:  Zackary Herbst; Coleman T Turgeon; Chad Biski; Hamid Khaledi; Nancy B Shoemaker; Patrick D DeArmond; Sara Smith; Joseph Orsini; Dietrich Matern; Michael H Gelb
Journal:  Int J Neonatal Screen       Date:  2020-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.